Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo - PubMed (original) (raw)
Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo
M Fràter-Schröder et al. Proc Natl Acad Sci U S A. 1987 Aug.
Abstract
Tumor necrosis factor type alpha (TNF-alpha) inhibits endothelial cell proliferation in vitro. Basal cell growth (in the absence of exogenously added growth factor) and fibroblast growth factor (FGF)-stimulated cell proliferation are inhibited in a dose-dependent manner from 0.1 to 10 ng/ml with half-maximal inhibition occurring at 0.5-1.0 ng of TNF-alpha per ml. Bovine aortic and brain capillary endothelial and smooth muscle cells are similarly affected. TNF-alpha is a noncompetitive antagonist of FGF-stimulated cell proliferation. Its action on endothelial cells is reversible and noncytotoxic. Surprisingly, TNF-alpha does not seem to inhibit endothelial cell proliferation in vivo. In the rabbit cornea, even a high dose of TNF-alpha (10 micrograms) does not suppress angiogenesis induced by basic FGF. On the contrary, in this model system TNF-alpha stimulates neovascularization. The inflammatory response that is seen in the cornea after TNF-alpha implantation suggests that the angiogenic properties of this agent may be a consequence of leukocyte infiltration.
Similar articles
- Tumor necrosis factor inhibits the proliferation of cultured capillary endothelial cells.
Schweigerer L, Malerstein B, Gospodarowicz D. Schweigerer L, et al. Biochem Biophys Res Commun. 1987 Mar 30;143(3):997-1004. doi: 10.1016/0006-291x(87)90350-0. Biochem Biophys Res Commun. 1987. PMID: 2436621 - Actions of tumor necrosis factor on cultured vascular endothelial cells: morphologic modulation, growth inhibition, and cytotoxicity.
Sato N, Goto T, Haranaka K, Satomi N, Nariuchi H, Mano-Hirano Y, Sawasaki Y. Sato N, et al. J Natl Cancer Inst. 1986 Jun;76(6):1113-21. J Natl Cancer Inst. 1986. PMID: 3458948 - Inhibition of tumor-induced migration of bovine capillary endothelial cells by mouse and rabbit tumor necrosis factor.
Mano-Hirano Y, Sato N, Sawasaki Y, Haranaka K, Satomi N, Nariuchi H, Goto T. Mano-Hirano Y, et al. J Natl Cancer Inst. 1987 Jan;78(1):115-20. doi: 10.1093/jnci/78.1.115. J Natl Cancer Inst. 1987. PMID: 2432305 - Bovine brain and pituitary fibroblast growth factors: comparison of their abilities to support the proliferation of human and bovine vascular endothelial cells.
Gospodarowicz D, Cheng J, Lirette M. Gospodarowicz D, et al. J Cell Biol. 1983 Dec;97(6):1677-85. doi: 10.1083/jcb.97.6.1677. J Cell Biol. 1983. PMID: 6643574 Free PMC article. - Proliferative variability of endothelial clones derived from adult bovine aorta: influence of fibroblast growth factor and smooth muscle cell extracellular matrix.
Longenecker JP, Kilty LA, Ridge JA, Miller DC, Johnson LK. Longenecker JP, et al. J Cell Physiol. 1983 Jan;114(1):7-15. doi: 10.1002/jcp.1041140103. J Cell Physiol. 1983. PMID: 6219118
Cited by
- Trauma promotes heparan sulfate modifications and cleavage that disrupt homeostatic gene expression in microvascular endothelial cells.
Richter RP, Odum JD, Margaroli C, Cardenas JC, Zheng L, Tripathi K, Wang Z, Arnold K, Sanderson RD, Liu J, Richter JR. Richter RP, et al. Front Cell Dev Biol. 2024 Jul 24;12:1390794. doi: 10.3389/fcell.2024.1390794. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39114570 Free PMC article. - Summary of the Therapeutic Options for Patients with Dry and Neovascular AMD.
Śpiewak D, Drzyzga Ł, Dorecka M, Wyględowska-Promieńska D. Śpiewak D, et al. J Clin Med. 2024 Jul 19;13(14):4227. doi: 10.3390/jcm13144227. J Clin Med. 2024. PMID: 39064267 Free PMC article. Review. - Targeting cytokine and chemokine signaling pathways for cancer therapy.
Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z. Yi M, et al. Signal Transduct Target Ther. 2024 Jul 22;9(1):176. doi: 10.1038/s41392-024-01868-3. Signal Transduct Target Ther. 2024. PMID: 39034318 Free PMC article. Review. - Phytochemicals Showing Antiangiogenic Effect in Pre-clinical Models and their Potential as an Alternative to Existing Therapeutics.
Senrung A, Tripathi T, Aggarwal N, Janjua D, Yadav J, Chaudhary A, Chhokar A, Joshi U, Bharti AC. Senrung A, et al. Curr Top Med Chem. 2024;24(4):259-300. doi: 10.2174/0115680266264349231016094456. Curr Top Med Chem. 2024. PMID: 37867279 Review. - Nanofiber Fractionalization Stimulates Healing of Large Intestine Anastomoses in Rabbits.
Kralovic M, Vjaclovsky M, Tonar Z, Grajciarova M, Lorenzova J, Otahal M, Necas A, Hoch J, Amler E. Kralovic M, et al. Int J Nanomedicine. 2022 Dec 14;17:6335-6345. doi: 10.2147/IJN.S364888. eCollection 2022. Int J Nanomedicine. 2022. PMID: 36540375 Free PMC article.
References
- EMBO J. 1985 Aug;4(8):1951-6 - PubMed
- Science. 1985 Nov 22;230(4728):943-5 - PubMed
- J Exp Med. 1985 Dec 1;162(6):2163-8 - PubMed
- Jpn J Cancer Res. 1985 Oct;76(10):989-94 - PubMed
- Proc Natl Acad Sci U S A. 1986 Jan;83(2):446-50 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources